Т-регуляторные клеткиинтерферон альфаметастатический почечно-клеточый ракT-regulatory cells CD4⁺CD25⁺interferon alphametastatic renal cell carcinoma1.Sakaguchi S. Naturally arising FOXP3-ex-pressing CD25+CD4+ regulatory T-cells in immunological tolerance to self and nonself. Nat Immunology 2005;6(4):345-52. DOI: 10.1038/ni1178. PMID: 15785760.2.Wei W.Z., Morris G.P., Kong Y.C. Anti-tumor immunity and autoimmunity: a balancing act of regulatory T-cells. Cancer Immunol Immunother 2004;53(2):73-8. DOI: 10.1007/s00262-003-0444-1. PMID: 14610619.3.Кадагидзе З.Г., Черткова А.И., Славина Е.Г. Иммунорегуляторные CD25+C-D4+-Т-клетки. Российский биотерапевтический журнал 2006;5(2):13-20.4.Baecher-Allan C., Brown J., Freeman G. et al. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001;167(3):1245-53. PMID: 11466340.5.Быковская С.Н., Карасев А.В., Лохонина А.В., Клейменова Е.Б. Анализ Т-регуляторных клеток CD4+CD25+FOXP3+ при аутоиммунных заболеваниях. Молекулярная медицина 2013;3:20-8.6.Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T-cells 2'2017 том 16 I vol. 16 in the human immune system. Nat Rev Immunol 2010;10(7):490-500. DOI: 10.1038/nri2785. PMID: 20559327.7.Gambineri E., Torgerson T., Ochs H. Immune dysregulation, polyendocrinopathy, enteropathy and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003;15(4):430-5. PMID: 12819471.8.Liu W., Putnam A., Xu-Yu Z. et al. CD127 expression inversely correlates with FOXP3 and suppressive function of human CD4+Treg cells. J Exp Med 2006;203(7):1701-11. DOI: 10.1084/jem.20060772. PMID: 16818678. PMCID: PMC2118339.9.Yang Z.Z., Ansell S.M. The role of Treg-cells in the cancer immunological response. Am J Immunol 2009;5(1):17-28.10.Lуez-Hoyos M., Segundo D., Arias M. Cellular immunotolerance in the transplant. Adv Exp Med Biol 2012;741:44-59. DOI: 10.1007/978-1-4614-2098-9_4. PMID: 22457102.11.Жулай Г.А., Олейник Е.К. Регуляторные Т-лимфоциты CD4+CD25+FOXP3+. Перспективы применения в иммунотерапии. Труды Карельского научного центра РАН 2012;2:3-17.12.Workman C., Szymczak-Wrrkman A., Collison L. et al. The development and function of regulatory T-cells. Cell Mol Life Sci 2009;66(16):2603-22. DOI: 10.1007/s00018-009-0026-2. PMID: 19390784. PMCID: PMC2715449.13.Thornton A., Korty P., Tran D. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced FOXP3+ T-regulatory cells. J Immunol 2010;184(7):3433-41. DOI: 10.4049/jimmunol.0904028. PMID: 20181882. PMCID: PMC3725574.14.Baron U., Floess S., Wieczorek G. et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T-cells from activated FOXP3+ conventional T-cells. Eur J Immunol 2007;37(9):2378-89. DOI: 10.1002/eji.200737594. PMID: 17694575.15.Janson P.C., Winerdal M.E., Marits P. et al. FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS One 2008;3(2):e1612. DOI: 10.1371/journal.pone.0001612. PMID: 18286169.16.Hawiger D., Wan Y.Y., Eynon E.E., Flavell R.A. Homeodomain only protein is required for the function of induced regulatory T-cells in dendritic cell-mediated peripheral T-cell unresponsiveness. Nat Immunol 2010;11(10):962-8. DOI: 10.1038/ni.1929. PMID: 20802482.17.Tran D.Q., Andersson J., Hardwick D. et al. Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T-cells allows for their purification from expansion cultures. Blood 2009;113(21):5125-33. DOI: 10.1182/blood-2009-01-199950. PMID: 19299332.18.Elkorda E., Sharma S., Burt D.J., Hawkins R.E. Expanded subpopulation of F OXP3+ T-regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs. Clin Immonol 2011;140(3):218-22. DOI: 10.1016/j.clim.2011.04.014. PMID: 21570917.19.Siddiqui SA., Frigola X., Bonne-Annee S. et al. Tumor-infiltrating FOXP3- CD4+CD25+ T-cells predict poor survival in renal cell carcinoma. Clin Cancer Res 2007;13(7):2075-81. DOI: 10.1158/1078-0432.CCR-06-2139. PMID: 17404089.20.Cesana G.C., DeRaffele G., Cohen S. et al. Characterization of CD4+CD25+ regulatory T-cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. J Clin Oncol 2006;24(7):1169-77. DOI: 10.1200/JCO.2005.03.6830. PMID: 16505437.21.Schwarzer A., Wolf B., Fisher J.L. et al. Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapy. PLoS One. 2012;7(10):e46600. DOI: 10.1371/journal.pone.0046600. PMID: 23118856.22.Finke J.H., Rini B., Ireland J. et al. Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients. Clin Cancer Res 2008;14(20):6674-82. DOI: 10.1158/1078-0432.CCR-07-5212. PMID: 18927310.23.Носов Д.А. Метастатический рак почки: новые лекарственные возможности и рациональные лечебные подходы. Автореф. дис.. д-ра мед. наук. М., 2012. 201 с.